Raindrop Raises $15 Million to Detect Critical AI Agent Failures

“Like Sentry, but for AI Agents” – Funding led by Lightspeed Venture Partners will enable Raindrop to meet enterprise demand and become the default monitoring solution for AI agents. Raindrop, the monitoring platform for AI agents, announced $15M in seed funding led by Lightspeed Venture Partners. The funding will enable Raindrop to meet enterprise demand, […]

Alan Mruvka’s VERZA TV to Launch With 80 Original Titles — Becoming the First U.S.-Based Vertical Micro-Drama App

Media pioneer Alan Mruvka, the co-founder of E! Entertainment Television, today announced the official launch of VERZA TV, the first U.S.-based mobile app dedicated primarily to vertical micro-dramas. The platform debuts with an unprecedented 80 original titles, immediately positioning VERZA TV as the new leader in short-form, serialized, premium storytelling built exclusively for mobile-first audiences.

Circular Genomics Announces Closure of $15 Million Series A Financing to Advance First-in-Class Circular RNA Platform for Early Detection of Alzheimer’s Disease

Financing accelerates clinical validation and commercial readiness, as circular RNAs emerge as a new category of brain-derived blood biomarkers with best-in-class performance Circular Genomics, Inc., the world-leading developer of circular RNA-based precision medicine tools for neurology and psychiatry, today announced the successful closure of a $15 million Series A financing round. The financing was led

DoubleLine Opportunistic Credit Fund Declares December 2025 Distribution

TheDoubleLine Opportunistic Credit Fund (the “Fund”), which is traded on the New York Stock Exchange under the symbol DBL, this week declared a distribution of $0.11 per share for the month of December 2025. The distribution is subject to the following ex-dividend, record and payment dates set by the Fund's Board of Trustees. https://mma.prnewswire.com/media/752903/DoubleLine_Logo.jpg December

Thompson Thrift Announces the Development of Canopy Flats, a Luxury Multifamily Community near Kansas City

Thompson Thrift, a full-service real estate company and one of the nation's leading multifamily developers, today announced the start of construction on Canopy Flats, a Class A multifamily community located along Metcalf Avenue in Overland Park. https://mma.prnewswire.com/media/2645557/Thompson_Thrift_Top_Workplaces_2025_Logo.jpg “We're proud to expand our presence in the Kansas City area with a community that reflects our commitment

Stride, Inc. (LRN) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Stride, Inc. (NYSE: LRN) securities between October 22, 2024 and October 28, 2025, all dates inclusive (the “Class Period”), have until January 12, 2026 to seek appointment as lead plaintiff of the Stride class action lawsuit. Captioned MacMahon v. Stride, Inc., No. 25-cv-02019

XENOVIEW(R) 3T coil passes Philips compatibility testing

(LSE:POLX), DURHAM, NC and LONDON, Dec. 01, 2025 (GLOBE NEWSWIRE) — Polarean Imaging plc (AIM: POLX), a commercial-stage medical device leader in advanced Magnetic Resonance Imaging (“MRI”) of the lungs, announces that its FDA-cleared XENOVIEW(R) 3T Chest Coil has successfully completed compatibility testing conducted by Philips (Philips Medical Systems Nederland B.V.) and is now confirmed

VetosEurope awarded ‘Best Company for Decarbonisation in the Beef Industry’ by World Finance magazine

News provided by World News Media World Financetodayannounced that VetosEurope has been named'Best Company for Decarbonisation in the Beef Industry' in theWorld FinanceCarbon Awards 2025. The recognition highlights the company's leadership in advancing sustainable livestock agriculture through its pioneering initiatives in methane mitigation and carbon credit development. VetosEurope was adjudged the winner for demonstrating outstanding

XENOVIEW(R) 3T coil passes Philips compatibility testing

XENOVIEW(R) 3T coil passes Philips compatibility testing Polarean's FDA cleared coil achieves important milestone, expanding clinical reach GlobeNewswire December 01, 2025 DURHAM, NC and LONDON, Dec. 01, 2025 (GLOBE NEWSWIRE) — Polarean Imaging plc (AIM: POLX), a commercial-stage medical device leader in advanced Magnetic Resonance Imaging (“MRI”) of the lungs, announces that its FDA-cleared XENOVIEW(R)

Scroll to Top